HDR Brachytherapy vs SABR in Early-intermediate Prostate Cancer

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
This is single center prospective phase 2 randomized trial aiming to compare biochemical and clinical relapse free survival and toxicity profiles of stereotactic body radiotherapy (SBRT) versus high dose rate brachytherapy (HDRB) for localized low- and intermediate risk prostate cancer patients.
Epistemonikos ID: 692a37d3aa9d27d8c524332cf0f652135d652167
First added on: May 08, 2024